The compliance calendar problem is specific. It isn’t about whether organizations understand the EU AI Act’s new deadlines, it’s about who the delay actually protects, and who it doesn’t.
The European Commission published a 167-page draft consultation on Article 6 high-risk AI classification on May 19, 2026. The consultation is open through June 23. Those facts have been widely covered. What’s emerged in the days since, in legal analysis published by Gibson Dunn and commentary in The Lens, is a structural read of the Omnibus delay that has direct consequences for organizations with product launches scheduled between now and the end of next year.
Here’s the problem legal analysts have identified. The EU AI Act originally set August 2, 2026 as the compliance deadline for standalone high-risk AI systems (Article 6(2), Annex III, biometrics, employment, education, creditworthiness, essential services). The Omnibus extended that deadline 16 months to December 2, 2027. It also extended the embedded high-risk deadline (Article 6(1), Annex I, AI integrated into medical devices, machinery, aviation safety components) from August 2, 2027 to August 2, 2028.
The grandfathering mechanism was designed to protect systems already on the market. It isn’t clear, according to legal analysts including commentary published in The Lens on May 27, that the Omnibus delay extended the grandfathering cutoff date to match the new enforcement deadline. If the grandfathering exemption remains tied to the original August 2, 2026 market-entry date, then a system placed on the EU market on August 3, 2026, one day after the original deadline, may not qualify for grandfathering, despite the enforcement deadline now sitting 16 months further out.
Unanswered Questions
- Does the Omnibus delay extend the grandfathering exemption cutoff date, or does it remain August 2, 2026?
- Which market-entry scenarios in the August 2026 – December 2027 window require full Annex III conformity assessment?
- Will the European Commission issue clarifying guidance before August 2, 2026 on grandfathering eligibility?
This interpretation hasn’t been confirmed by the European Commission. It is legal analysis, not regulatory fact. But it’s actionable analysis.
Don’t expect the Commission to clarify this gap before August 2. The consultation on the draft guidelines closes June 23, and the guidelines themselves cover classification scope, not the grandfathering interaction. Organizations waiting for official clarification before deciding on market entry timing are taking a planning risk.
The practical implication for compliance teams: if your organization is considering EU market entry for a high-risk AI system in Q3 or Q4 2026, the August 2 date matters more than the December 2027 enforcement headline suggests. The 16-month delay protects systems already on the market and systems that complete compliance before December 2027. It may not protect systems that enter the market in the window between those two dates without having completed conformity assessment.
Warning
This gap is legal analysis, not confirmed regulatory fact. But organizations planning EU market entry in Q3–Q4 2026 should treat the August 2 date as a live planning risk until the European Commission provides explicit clarification.
The real question is whether legal counsel for organizations in this planning window is treating the grandfathering cutoff as a confirmed August 2 date and building compliance timelines accordingly, or assuming the delay extended all of the original protections. The Gibson Dunn client alert published May 27 is the most recent authoritative legal read on the Omnibus changes and is worth reviewing in full before any Q3 2026 EU market entry decision.
Prior TJS coverage of the Article 6 guidelines and the broader EU AI Act deadline framework is available at the EU AI Act deadline overview brief and the three-pathway deadline guide.